Cervical pessary reduces spontaneous delivery before 34 weeks and adverse outcomes in pregnant women with a short cervix
- Department of Obstetrics and Gynecology, Pennsylvania Hospital/University of Pennsylvania Health System, Penn Medicine, Philadelphia, Pennsylvania, USA
- Correspondence to
: Dr Jack Ludmir
Department of Obstetrics and Gynecology, Pennsylvania Hospital/University of Pennsylvania Health System, Penn Medicine, two Pine East, Pennsylvania Hospital, 800 Spruce St Philadelphia, PA 19107-6192, USA;
- Accepted 6 August 2012
- Published Online First 29 August 2012
Commentary on: Goya M, Pratcorona L, Merced C, et al. Pesario Cervical para Evitar Prematuridad (PECEP) Trial Group. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012;379:1800–6.
Prematurity prevention continues to be one of the biggest challenges in perinatal medicine. Most pregnancies complicated by preterm birth occur in gestations without any historical risk factors. The most effective therapeutic approach for the asymptomatic patient with a short cervix continues to evolve. For over 50 years, the cervical pessary has been used to treat women at risk of cervical insufficiency and preterm delivery. However, the value of the pessary in preventing prematurity in patients without historical risk factors has not been properly studied.
The cervical pessary in pregnant women with a short cervix (PECEP) trial by Goya and colleagues, represents the …